Why endocannabinoids are not all alike
- 1 February 2008
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 11 (2) , 124-126
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatumNature Neuroscience, 2008
- Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid releaseNeuropharmacology, 2008
- Biochemistry and pharmacology of endovanilloidsPharmacology & Therapeutics, 2007
- Phospholipase Cβ3 is distributed in both somatodendritic and axonal compartments and localized around perisynapse and smooth endoplasmic reticulum in mouse Purkinje cell subsetsEuropean Journal of Neuroscience, 2007
- Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerolThe Journal of Physiology, 2006
- Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channelsThe EMBO Journal, 2005
- Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdalaEuropean Journal of Neuroscience, 2004
- Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brainCellular and Molecular Life Sciences, 2004
- Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine bindingProstaglandins, Leukotrienes and Essential Fatty Acids, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992